Q4 Results Live Updates
Emcure FY26 revenue rises 16.6% to ₹9,204 crore, PAT grows 33.1%
13 Jun 26Emcure Pharmaceuticals reported a 16.6% YoY rise in revenue to ₹9,204 crore for FY26, driven by international growth. PAT increased 33.1% to ₹941 crore, with EBITDA margins expanding 83 bps to 19.4%.
view all stories

Latest Market Updates
Today's Top Gainers





Today's Top Losers





Today's Top Gainers





Today's Top Losers












































